Key terms

About ONCY

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ONCY news

Today 7:48am ET Oncolytics Biotech to Present at ASCO Meeting by TipRanks Apr 12 11:57am ET Oncolytics Biotech Sets Virtual Annual Meeting by TipRanks Apr 11 2:37pm ET Oncolytics Biotech Eyes Milestone in Breast Cancer Trial by TipRanks Apr 11 7:12am ET Oncolytics submits Type C meeting request to FDA by TipRanks Apr 04 8:22am ET Oncolytics initiated with an Outperform at Raymond James by TipRanks Apr 02 8:27am ET Oncolytics Biotech Showcases at Oncology Event by TipRanks Apr 02 7:48am ET Oncolytics Biotech Showcases at Oncology Conference by TipRanks Mar 09 12:25pm ET Buy Rating Affirmed for Oncolytics Biotech Amidst Promising Pipeline and Advancements in Cancer Treatment Trials by TipRanks Mar 08 4:25pm ET Buy Rating Affirmed on Oncolytics Biotech Amid Progress and Strategic Clinical Trials by TipRanks Mar 08 12:35pm ET Maintaining Buy Rating on ONCY Amidst Promising Clinical Advancements and Partnership Potential by TipRanks Mar 08 7:27am ET Oncolytics Biotech (ONCY) Gets a Buy from RBC Capital by TipRanks Mar 07 4:38pm ET Oncolytics Biotech Shows Promising Cancer Drug Progress by TipRanks Mar 05 7:50am ET Oncolytics Biotech Expands Pancreatic Cancer Study by TipRanks Feb 28 7:40am ET Oncolytics Biotech Spotlights at NeauxCancer Conference by TipRanks Feb 14 9:55am ET Reiterating Buy Rating: Expanding Potential of Pelareorep in Oncolytics Biotech’s Pipeline by TipRanks Feb 14 7:09am ET Oncolytics expands enrollment for GOBLET study evaluating pelareorep by TipRanks
Mar 06 3:00am ET Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning by Newsfile Feb 15 3:00am ET Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments by NewsFile

ONCY Financials

1-year income & revenue

Key terms

ONCY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ONCY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

GettyImages-1159438448 copy.jpg
Lyndon Stratford/iStockphoto/Getty Images
Americans are falling behind on their payments
Meta headquarters pictured on February 02, 2023 in Menlo Park, California.
Justin Sullivan/Getty Images
Meta’s stock plunges on ‘aggressive’ AI spending plans
The logo of Swiss bank UBS is seen at the company's headquarters in Zurich, Switzerland February 10, 2015. REUTERS/Arnd Wiegmann/File Photo
Arnd Wiegmann/Reuters
Switzerland says UBS may need more cash. The bank is fuming
Jamie Dimon, Chairman and Chief Executive officer (CEO) of JPMorgan Chase & Co. (JPM) speaks to the Economic Club of New York in Manhattan in New York City, U.S., April 23, 2024. REUTERS/Mike Segar
Mike Segar/Reuters
Jamie Dimon fears for the future of the free world and US debt